Amplia Therapeutics Limited (INNMF)

Revenue by Product

Financials in millions AUD. Fiscal year is April - March.

Year Ending	Mar 31, 2023	Mar 31, 2022
Focal Adhesion Kinase	15.00K
Focal Adhesion Kinase Growth	-63.46%

Revenue by Geography

Financials in millions AUD. Fiscal year is April - March.

Year Ending	Mar 31, 2023	Mar 31, 2022
Australia	15.00K
Australia Growth	-63.46%